Stocktwits on MSN
SPRY, PASG, BOXL: Why these stocks plunged double digits in after-hours trading today
ARS Pharmaceuticals shares tumbled after the company said Neffy failed to secure expanded commercial insurance coverage for ...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...
Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...
Asianet Newsable on MSN
PASG stock slumps 16% after-hours — what’s driving the selloff?
Passage Bio said on Wednesday that it will merge with privately held Remix Therapeutics.
Capital Management LP Lynx1, a 10% owner of $PASG, bought 13,123 shares of the company on 07-22-2025 for an estimated $71,337. This trade was reported by Quiver ...
Passage Bio Inc. Annual stock financials by MarketWatch. View the latest PASG financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results